Rehabilitation Through Individualized Support and Exercise (RISE)

September 30, 2026 updated by: Universitaire Ziekenhuizen KU Leuven

Feasibility and Compliance of a Tailored Physiotherapy Program for Early Mobilization After Oral Cancer Surgery

Oral cancer, the most prevalent form of head and neck malignancy, represents a major global health burden, with over 370,000 new cases annually according to the World Health Organization. Surgical resection with free flap reconstruction remains the gold standard for curative treatment, yet it often entails significant functional and physical impairment. The surgical procedure often involves tumor resection and reconstruction. Postoperative complications such as dysphagia, reduced masticatory function, and prolonged immobility frequently contribute to fatigue, loss of muscle mass, and delayed recovery, ultimately impacting quality of life and overall prognosis.

Loss of skeletal muscle mass, commonly observed in this patient population, is strongly associated with impaired physical performance, reduced treatment tolerance, and increased postoperative morbidity. Recent evidence underscores that early mobilization and structured physiotherapeutic interventions can mitigate these effects, enhance functional recovery, and reduce length of hospital stay across various surgical populations. In head and neck cancer specifically, early mobilization has been associated with shorter hospitalization and fewer complications, yet practical, standardized physiotherapy protocols remain scarce and poorly defined.

Despite inclusion of early mobilization principles in Enhanced Recovery After Surgery (ERAS) pathways, current head and neck cancer guidelines lack specific recommendations regarding the timing, intensity, and content of postoperative physical activity. Furthermore, evidence on patient compliance and feasibility of such interventions during the acute hospitalization phase is limited.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

39

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Leuven, Belgium, 3000
        • UZ Leuven
        • Contact:
        • Sub-Investigator:
          • Jeroen Van Dessel, Dr.
        • Principal Investigator:
          • Robin Willaert, Prof. Dr.
        • Sub-Investigator:
          • Lina Van Lint, MSc
        • Sub-Investigator:
          • Lynn Christiaens, MSc
        • Sub-Investigator:
          • Auke Van Mierlo, Dr.
        • Sub-Investigator:
          • Karla Van de Velde, MSc

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria:

  • Age ≥18 years.
  • Histologically confirmed oral cancer.
  • Planned free fibula or DCIA flap reconstruction.
  • Ability to provide written informed consent.
  • Sufficient comprehension of Dutch to complete questionnaires.

Exclusion criteria:

  • Severe psychiatric or neurocognitive impairment (e.g., dementia, Korsakoff syndrome, schizophrenia).
  • Hemodynamic instability or contraindication to mobilization.
  • Pre-existing neuromuscular disorders severely limiting mobility.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental

Patients get a tailored physiotherapy program for early mobilization after oral cancer surgery

Participants allocated to the intervention group will receive a structured, multicomponent exercise programme during the perioperative period in addition to usual care. The programme includes individually tailored aerobic, resistance, flexibility and functional exercises, supervised by trained healthcare professionals and progressively adapted according to the participant's clinical condition and recovery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Achievement of the highest exercise progression level
Time Frame: From the first postoperative physiotherapy session until hospital discharge, anticipated from day 1 to 10 after surgery.

The percentage of participants who achieve the highest exercise progression level of the postoperative physiotherapy programme before hospital discharge will be reported. The highest progression level is defined as Level 4. The percentage will be calculated as the number of participants achieving this level divided by the total number of participants included in the primary feasibility analysis (n=35), multiplied by 100.

From the first postoperative physiotherapy session until hospital discharge, anticipated from day 1 to 10 after surgery.
Patient-reported acceptability of the intervention
Time Frame: At hospital discharge, anticipated 10 days after surgery.

Patient-reported acceptability of the physiotherapy programme will be assessed using the Acceptability of Intervention Measure (AIM). The AIM consists of four items, each rated from 1 (completely disagree) to 5 (completely agree). The participant-level score will be calculated as the mean of the four item scores, ranging from 1 to 5. Higher scores indicate greater perceived acceptability.

At hospital discharge, anticipated 10 days after surgery.
Patient-reported appropriateness of the intervention
Time Frame: At hospital discharge, anticipated 10 days after surgery.

Patient-reported appropriateness of the physiotherapy programme will be assessed using the Intervention Appropriateness Measure (IAM). The IAM consists of four items, each rated from 1 (completely disagree) to 5 (completely agree). The participant-level score will be calculated as the mean of the four item scores, ranging from 1 to 5. Higher scores indicate greater perceived appropriateness.

At hospital discharge, anticipated 10 days after surgery.
Patient-reported feasibility of the intervention
Time Frame: At hospital discharge, anticipated 10 days after surgery.

Patient-reported feasibility of the physiotherapy programme will be assessed using the Feasibility of Intervention Measure (FIM). The FIM consists of four items, each rated from 1 (completely disagree) to 5 (completely agree). The participant-level score will be calculated as the mean of the four item scores, ranging from 1 to 5. Higher scores indicate greater perceived feasibility.

At hospital discharge, anticipated 10 days after surgery.
Adherence to prescribed physiotherapy sessions
Time Frame: From the first prescribed postoperative physiotherapy session until hospital discharge, anticipated from day 1 to 10 after surgery.

Adherence will be assessed as the percentage of prescribed postoperative physiotherapy sessions completed by each participant. This percentage will be calculated as the number of completed sessions divided by the number of prescribed and clinically eligible sessions during the postoperative hospital stay, multiplied by 100. A completed session is defined as a supervised physiotherapy session that is initiated and delivered as planned or with clinically indicated adaptations. Sessions that are initiated but terminated before completion will be classified as incomplete, with the reason for termination recorded. Sessions withheld or terminated because the participant is clinically ineligible for physiotherapy or because of safety concerns will be reported separately and excluded from the denominator. Scores range from 0% to 100%, with higher percentages indicating greater adherence.

From the first prescribed postoperative physiotherapy session until hospital discharge, anticipated from day 1 to 10 after surgery.
Therapist-rated adherence to physiotherapy
Time Frame: Immediately after each postoperative physiotherapy session, from the first session until hospital discharge, anticipated from day 1 to 10 after surgery.

Therapist-rated in-session engagement will be assessed immediately after each postoperative physiotherapy session using the Sport Injury Rehabilitation Adherence Scale (SIRAS). The SIRAS consists of three items, each scored from 1 to 5. Item scores are summed to obtain a session-level total score ranging from 3 to 15, with higher scores indicating greater in-session engagement. The reported participant-level outcome will be the mean of the session-level total scores across all assessed sessions.

Immediately after each postoperative physiotherapy session, from the first session until hospital discharge, anticipated from day 1 to 10 after surgery.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Objectively measured physical activity
Time Frame: From baseline (8 days before surgery) until the end of follow-up (10 days after discharge).

Physical activity will be continuously assessed using the Activ8 Physical Activity Monitor G2. Activity data will be collected throughout the perioperative period to quantify daily physical activity and sedentary behaviour. Participant diaries will be used to support interpretation of activity monitor data during the preoperative and post-discharge periods.

From baseline (8 days before surgery) until the end of follow-up (10 days after discharge).
Anxiety symptoms
Time Frame: At baseline, 8 days before surgery

Anxiety symptoms will be assessed preoperatively using the Generalized Anxiety Disorder 2-item scale (GAD-2), with a total score ranging from 0 to 6. Higher scores indicate greater anxiety symptom severity and therefore a worse outcome. Participants scoring ≥3 will additionally complete the Generalized Anxiety Disorder 7-item scale (GAD-7), with a total score ranging from 0 to 21. Higher GAD-7 scores indicate greater anxiety symptom severity and therefore a worse outcome.

At baseline, 8 days before surgery
Baseline physical activity
Time Frame: At baseline, 8 days before surgery

Baseline physical activity and sedentary behaviour will be assessed using the Simple Physical Activity Questionnaire (SIMPAQ). The SIMPAQ assesses time spent across five activity domains: time in bed, sedentary time, walking, structured exercise, and incidental physical activity. Outcomes are reported as time spent in each activity domain rather than as a total score; therefore, no overall minimum or maximum score or direction of better outcome applies.

At baseline, 8 days before surgery
Motivation for physical activity
Time Frame: At baseline, 8 days before surgery, and at the start of the intervention, anticipated 1 day after surgery.

Motivation for physical activity will be assessed using the Behavioral Regulation in Exercise Questionnaire-3 (BREQ-3). The questionnaire assesses six forms of motivation: amotivation, external regulation, introjected regulation, identified regulation, integrated regulation, and intrinsic regulation. Each subscale is scored from 0 to 4. Higher scores indicate a greater presence of the respective type of motivation. Higher identified, integrated, and intrinsic regulation scores reflect greater autonomous motivation (better outcomes), whereas higher amotivation reflects lower motivation (worse outcome). External and introjected regulation represent more controlled forms of motivation and cannot be uniformly interpreted as better or worse outcomes. No overall BREQ-3 total score is calculated.

At baseline, 8 days before surgery, and at the start of the intervention, anticipated 1 day after surgery.
Functional lower limb performance measured by the Five Times Sit-to-Stand Test
Time Frame: At baseline, 8 days before surgery, and at hospital discharge, anticipated 10 days after surgery.

Functional lower limb performance will be assessed using the Five Times Sit-to-Stand Test (5xSTS). The time required to complete five consecutive sit-to-stand repetitions will be recorded in seconds. Shorter completion times indicate better functional lower limb performance. Completion times will be reported at each assessment time point.

At baseline, 8 days before surgery, and at hospital discharge, anticipated 10 days after surgery.
Functional exercise capacity measured by the Six-Minute Walk Test
Time Frame: At baseline, 8 days before surgery, and at hospital discharge, anticipated 10 days after surgery.

Functional exercise capacity will be assessed using the Six-Minute Walk Test (6MWT). The total distance walked during six minutes will be recorded in metres. Greater walking distances indicate better functional exercise capacity. Walking distances will be reported at each assessment time point.

At baseline, 8 days before surgery, and at hospital discharge, anticipated 10 days after surgery.
Handgrip strength
Time Frame: At baseline, 8 days before surgery, and at hospital discharge, anticipated 10 days after surgery.

Handgrip strength will be assessed using a Jamar Hydraulic Hand Dynamometer and recorded in kilograms. Three attempts will be performed for each hand at each assessment time point. The mean of the three attempts will be calculated separately for the right and left hand, and results will be reported separately by hand. Higher values indicate greater handgrip strength.

At baseline, 8 days before surgery, and at hospital discharge, anticipated 10 days after surgery.
Pain intensity
Time Frame: From baseline (8 days before surgery) until the end of follow-up (10 days after discharge).

Pain intensity will be assessed using the Numeric Rating Scale (NRS), ranging from 0 to 10, where 0 represents no pain and 10 represents the worst possible pain. Higher scores indicate greater pain intensity and therefore a worse outcome. Pain scores will be recorded three times daily from the preoperative baseline assessment until 10 days after hospital discharge.

From baseline (8 days before surgery) until the end of follow-up (10 days after discharge).
Perceived exertion during physiotherapy
Time Frame: At the end of each supervised postoperative physiotherapy session, from the first session until hospital discharge, anticipated from day 1 to 10 after surgery.

Perceived exertion will be assessed using the Borg Rating of Perceived Exertion (RPE) scale at the end of each supervised postoperative physiotherapy session. The scale ranges from 6 (no exertion) to 20 (maximal exertion), with higher scores indicating greater perceived exertion. The reported participant-level outcome will be the mean of the session-level ratings across all assessed postoperative physiotherapy sessions.

At the end of each supervised postoperative physiotherapy session, from the first session until hospital discharge, anticipated from day 1 to 10 after surgery.
Length of hospital stay
Time Frame: From the day of surgery until hospital discharge, anticipated 10 days after surgery.

Length of hospital stay will be recorded as the number of days from surgery until hospital discharge.

From the day of surgery until hospital discharge, anticipated 10 days after surgery.
Postoperative complications
Time Frame: From surgery until the end of follow-up (12 weeks after surgery)

Postoperative complications will be recorded and classified according to the Common Terminology Criteria for Adverse Events (CTCAE), version 5.0. Adverse events are graded from 1 to 5, with higher grades indicating greater severity: Grade 1 (mild), Grade 2 (moderate), Grade 3 (severe), Grade 4 (life-threatening), and Grade 5 (death related to the adverse event). Higher grades therefore indicate a worse outcome. No overall score is calculated.

From surgery until the end of follow-up (12 weeks after surgery)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 10, 2026

Primary Completion (Estimated)

January 1, 2029

Study Completion (Estimated)

January 1, 2029

Study Registration Dates

First Submitted

August 5, 2026

First Submitted That Met QC Criteria

September 30, 2026

First Posted (Actual)

October 5, 2026

Study Record Updates

Last Update Posted (Actual)

October 5, 2026

Last Update Submitted That Met QC Criteria

September 30, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • S71815

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared due to participant confidentiality, ethical considerations, and institutional data protection policies.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.